Clinical Trials

$I-Mab receives China NMPA clearance to begin phase 1 trial of lemzoparlimab in relapsed/refractory advanced lymphoma$

I-Mab, a clinical stage biopharmaceutical company, announced that the Center for Drug Evaluation (CDE) of...

Regeneron Pharmaceuticals, Inc. and the University of Oxford today announced that RECOVERY (Randomised Evaluation of...

Sorrento Therapeutics, Inc. announced that it received a study may proceed letter from the FDA...

Pfizer Inc. and BioNTech SE announced that they have submitted an amended protocol to the...

Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition...

Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount,...

$Merck announces positive results phase 3 trials of gefapixant 45 mg twice daily in patients with refractory or unexplained chronic cough$

Merck, known as MSD outside the United States and Canada, has announced the results from...

Sharp - part of UDG Healthcare plc, a global leader in contract packaging clinical supply...

A COVID-19 vaccine candidate developed by Beijing-based Sinovac Life Sciences Corp has obtained preliminary approval...

Hyderabad-based Bharat Biotech has received approval to conduct phase II trials of its COVID-19 vaccine...